Physician profile
Patrick N Green
NPI 1144431800
$7,893.68
in general payments reported to CMS, 2019-2025
52 companies · $860 in 2025
The $860 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $845 · 2021: $1,142 · 2022: $1,426 · 2023: $1,316 · 2024: $1,198 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,161.97 | 2021-2025 | |
| Indivior INC. | $672.07 | 2019-2025 | Sublocade |
| Boehringer Ingelheim Pharmaceuticals, INC. | $384.44 | 2019-2023 | Spiriva Respimat, Stiolto Respimat, Jardiance |
| Astrazeneca Pharmaceuticals LP | $366.07 | 2019-2024 | Airsupra |
| Lilly USA, LLC | $362.24 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $342.65 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Allergan, INC. | $309.96 | 2019-2020 | |
| Abbott Laboratories | $285.79 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $257.78 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Medtronic, INC. | $233.85 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Minimed 770g |
| Mylan Specialty L.P. | $208.47 | 2019-2023 | Yupelri |
| Alkermes, INC. | $205.88 | 2020-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $170.00 | 2021-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $167.18 | 2022-2025 | |
| Antares Pharma, INC. | $166.01 | 2019-2022 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.